Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.23 - $0.46 $18,785 - $37,570
-81,676 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$0.55 - $1.04 $2,081 - $3,936
-3,785 Reduced 4.43%
81,676 $45,000
Q2 2021

Aug 16, 2021

SELL
$1.22 - $1.65 $9,750 - $13,186
-7,992 Reduced 8.55%
85,461 $129,000
Q1 2021

May 17, 2021

BUY
$1.18 - $2.62 $19,512 - $43,324
16,536 Added 21.5%
93,453 $144,000
Q4 2020

Feb 16, 2021

BUY
$1.05 - $2.24 $58,955 - $125,771
56,148 Added 270.35%
76,917 $81,000
Q3 2020

Nov 16, 2020

SELL
$1.7 - $6.41 $10,526 - $39,690
-6,192 Reduced 22.97%
20,769 $42,000
Q2 2020

Aug 14, 2020

BUY
$0.87 - $2.46 $23,456 - $66,324
26,961 New
26,961 $60,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.8M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.